Literature DB >> 1632187

Prothymosin alpha expression in lymph nodes and tonsils: an optical and ultrastructural study.

R Gallego1, E Rosón, T García-Caballero, M Fraga, J Forteza, F Domínguez, A Beiras.   

Abstract

Prothymosin alpha (ProT alpha) distribution in human and rat lymph nodes and human tonsils was studied by means of immunohistochemical methods, using specific antibodies raised against thymosin alpha 1. We observed ProT alpha immunoreactivity in lymphoid cells of the germinal centers both in humans and rats. In human tonsils, positive cells were also seen in the basal layer of the surface epithelium. These results support the hypothesis that ProT alpha expression is restricted to actively proliferating cells. Immunoelectron microscopy revealed that ProT alpha was located in the nucleus, mainly in the border between euchromatin and heterochromatin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632187     DOI: 10.1159/000147251

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  4 in total

1.  Apoptotic and proliferating hepatocytes differ in prothymosin alpha expression and cell localization.

Authors:  Luciana Barbini; Rosario Gonzalez; Fernando Dominguez; Felix Vega
Journal:  Mol Cell Biochem       Date:  2006-07-15       Impact factor: 3.396

2.  Evolution of prothymosin alpha and proliferating cell nuclear antigen (PCNA) immunoreactivity through the development of rat ovarian follicles.

Authors:  E Roson; R Gallego; T Garcia-Caballero; M Fraga; F Dominguez; A Beiras
Journal:  Histochem J       Date:  1993-07

3.  Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Ranju Ralhan; Leroi V Desouza; Ajay Matta; Satyendra Chandra Tripathi; Shaun Ghanny; Siddartha Datta Gupta; Sudhir Bahadur; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2008-03-13       Impact factor: 5.911

4.  Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer.

Authors:  C Magdalena; F Dominguez; L Loidi; J L Puente
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.